Groundbreaking advancements in GLP-1 are focusing on novel delivery methods, especially the development of swiftly disintegrating pills. These new formats seek to enhance individual compliance and potentially offer more rapid action, resulting to improved health effects. Researchers hypothesize that this approach holds significant potential for the